Powder: -20°C for 3 years | In solvent: -80°C for 1 year
EP3 antagonist 4 is an EP3 antagonist that inhibits hEP with a Ki of 2 nM. EP3 antagonist 4 showed low in vivo clearance, high oral AUC and good bioavailability in complete PK studies in rats. EP3 antagonist 4 can be used to study diabetes and cellular dysfunction.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | Inquiry | $ 195.00 | |
5 mg | Inquiry | $ 430.00 | |
10 mg | Inquiry | $ 650.00 | |
25 mg | Inquiry | $ 1,110.00 | |
50 mg | Inquiry | $ 1,680.00 | |
100 mg | Inquiry | $ 2,540.00 | |
500 mg | Inquiry | $ 5,588.00 |
Description | EP3 antagonist 4 is an EP3 antagonist that inhibits hEP with a Ki of 2 nM. EP3 antagonist 4 showed low in vivo clearance, high oral AUC and good bioavailability in complete PK studies in rats. EP3 antagonist 4 can be used to study diabetes and cellular dysfunction. |
Molecular Weight | 577.91 |
Formula | C22H20Cl3FN4O3S2 |
CAS No. | 2408297-80-1 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
EP3 antagonist 4 2408297-80-1 GPCR/G Protein Immunology/Inflammation Prostaglandin Receptor inhibitor inhibit